Kafrelsheikh University
Tanta, Egypt
NCT Number: NCT06016933
The purpose of this study is to assess the clinical and immunological effect of spirulina in treatment of stage II periodontitis.
Looking for future studies?
Notify Me35 year–50 year
All sexes
Interventional
Not applicable
Tanta, Egypt
In this study, the investigators tested the effect of spirulina gel as adjunctive of scaling and root planing in treatment of stage II, grade B periodontitis in term of probing pocket depth reduction, mean gain in clinical attachment level, and level of interleukin 6.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient were received spirulina gel in diseased sites. The process will be repeated at 7, 14, 21 days.
Patients received oral hygiene instructions and SRP of all teeth.
Time frame: 3 months
Clinical attachment level was measured at baseline, 1 and 3 months after gel application.
Time frame: 3 months
Probing pocket depth was measured at baseline, 1 and 3 months after gel application.
Time frame: 3 months
Enzyme linked immune-assay for the quantitative measurement of interleukin 6 concentration in gingival cervicular fluid at baseline, 1 and 3 months after gel application.
Time frame: 3 months
Plaque index was measured at baseline and at 1, and 3-months post treatment.
Time frame: 3 months
Gingival index was measured at baseline and at 1, and 3-months post treatment.
Kafrelsheikh University
Other
Effect of Locally Delivered Spirulina Gel on Treatment of Stage II, Grade B Periodontitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07791927
Gingival Diseases, Gingivitis
View Trial DetailsNCT07792902
Mouth Diseases, Periodontal Diseases
Ribeirão Preto, São Paulo, Brazil
View Trial DetailsNCT07788937
Mouth Diseases, Periodontal Diseases
Erzurum, Turkey (Türkiye)
View Trial DetailsNCT07782736
Mouth Diseases, Periodontal Diseases
Ho Chi Minh City, Vietnam
View Trial Details